The vaccine will be made from the tumors and immune cells of each patient. When a patient’s tumor is definitely removed during surgery it will be shipped to a laboratory where the tumor cells will end up being broken up to prepare the first component of the vaccine. Individually, sufferers’ dendritic cells, a powerful type of immune cell, will become obtained and sent to a laboratory for purification. Dendritic cells could probably teach the immune system to identify and destroy tumor cells. The patients’ tumor cell materials is combined with dendritic cells to form the vaccine.. Cancer vaccine coupled with hormone-deprivation therapy can help patients with recurrence of prostate cancer A fresh study finds that a cancer vaccine combined with hormone-deprivation therapy might help patients with recurrence of prostate cancer.General and administrative expenses were 2 NIS.48 million for the 90 days ended March 31, 2015 compared to NIS 2.94 million for the same period in 2014. The decrease is primarily due to a reduction in income and professional services expenses. Financial income, net for the three months ended March 31, 2015 aggregated NIS 3.3 million compared to NIS 0.5 million for the same period in 2014. The upsurge in financial income, net in the first quarter of 2015 was due mainly to a reduction in the fair value of warrants that are accounted as a monetary liability. Can-Fite's loss for the three months ended March 31, 2015 was NIS 1.51 million weighed against a loss of NIS 6.26 million for the same period in 2014. The reduction in net reduction for the first quarter of 2015 was attributable both to an increase in finance income, net, and a reduction in operating expenses.